A Genomic Screen for Modifiers of Tauopathy Identifies Puromycin-Sensitive Aminopeptidase as an Inhibitor of Tau-Induced Neurodegeneration
暂无分享,去创建一个
D. Geschwind | H. Vinters | R. Berry | S. Karsten | Shreyasi Chatterjee | G. Jackson | C. Schulz | L. Gehman | L. Binder | Hyun-Seok Oh | M. Wiedau-Pazos | J. Pomakian | Tzu-Kang Sang | Jiankai Liu | G. Lawless | K. Hui | Soma Sengupta
[1] M. Fortini,et al. RETRACTED: γ-Cleavage-Independent Functions of Presenilin, Nicastrin, and Aph-1 Regulate Cell-Junction Organization and Prevent Tau Toxicity In Vivo , 2006, Neuron.
[2] Mary Kay Lobo,et al. FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains , 2006, Nature Neuroscience.
[3] L. Honig,et al. Model‐guided microarray implicates the retromer complex in Alzheimer's disease , 2005, Annals of neurology.
[4] B. Hyman,et al. Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.
[5] F. Liu,et al. Post-translational modifications of tau protein in Alzheimer’s disease , 2005, Journal of Neural Transmission.
[6] P. Mcgeer,et al. Proteolysis of Non-phosphorylated and Phosphorylated Tau by Thrombin* , 2005, Journal of Biological Chemistry.
[7] S. Zipursky,et al. Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis. , 2005, Human molecular genetics.
[8] K. Kosik,et al. Phosphorylated tau and the neurodegenerative foldopathies. , 2005, Biochimica et biophysica acta.
[9] G. Schellenberg,et al. Regulation of tau isoform expression and dementia. , 2005, Biochimica et biophysica acta.
[10] T. Gillingwater,et al. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. , 2004, American journal of human genetics.
[11] Y. Tu,et al. Distinct Roles of Two Structurally Closely Related Focal Adhesion Proteins, α-Parvins and β-Parvins, in Regulation of Cell Morphology and Survival* , 2004, Journal of Biological Chemistry.
[12] Feng Chen,et al. Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals. , 2004, Current drug targets.
[13] C. Lomen‐Hoerth,et al. Characterization of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia , 2004, Dementia and Geriatric Cognitive Disorders.
[14] Jonathan Pevsner,et al. Progress in the use of microarray technology to study the neurobiology of disease , 2004, Nature Neuroscience.
[15] Feng Chen,et al. A complementary transposon tool kit for Drosophila melanogaster using P and piggyBac , 2004, Nature Genetics.
[16] C. Barbato,et al. Role of N-terminal tau domain integrity on the survival of cerebellar granule neurons , 2004, Cell Death and Differentiation.
[17] J. Shulman,et al. Genetic modifiers of tauopathy in Drosophila. , 2003, Genetics.
[18] D. Dickson,et al. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau , 2003, Journal of neurocytology.
[19] Jae K. Lee,et al. Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays , 2003, Bioinform..
[20] D. Dickson,et al. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. , 2003, The American journal of pathology.
[21] S. Meri,et al. Yin and Yang: complement activation and regulation in Alzheimer’s disease , 2003, Progress in Neurobiology.
[22] R. Berry,et al. Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[23] K. Hui,et al. Neuron-Specific Aminopeptidase and Puromycin-Sensitive Aminopeptidase in Rat Brain Development , 2003, Neurochemical Research.
[24] R. Vos,et al. Free insulin-like growth factor (IGF)-I and IGF binding proteins 2, 5, and 6 in spinal motor neurons in amyotrophic lateral sclerosis , 2003, The Lancet.
[25] Yoshio Yamamoto,et al. Demonstration of puromycin-sensitive alanyl aminopeptidase in Alzheimer disease brain. , 2003, Legal medicine.
[26] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[27] K. Kosik,et al. Discovery of compounds that will prevent tau pathology , 2002, Journal of Molecular Neuroscience.
[28] M. Spillantini,et al. Tau gene mutations: dissecting the pathogenesis of FTDP-17. , 2002, Trends in molecular medicine.
[29] C. Thompson,et al. Elongation factor-1 alpha is a selective regulator of growth factor withdrawal and ER stress-induced apoptosis , 2002, Cell Death and Differentiation.
[30] P. Hiesinger,et al. Drosophila VAP-33A Directs Bouton Formation at Neuromuscular Junctions in a Dosage-Dependent Manner , 2002, Neuron.
[31] D. Geschwind,et al. Human Wild-Type Tau Interacts with wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila , 2002, Neuron.
[32] Sangram S. Sisodia,et al. γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in? , 2002, Nature Reviews Neuroscience.
[33] I. Grundke‐Iqbal,et al. Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease , 2002, FEBS letters.
[34] M. Fuller,et al. Genetic analysis of dPsa, the Drosophila orthologue of puromycin-sensitive aminopeptidase, suggests redundancy of aminopeptidases , 2001, Development Genes and Evolution.
[35] Károly Mirnics,et al. Microarrays in brain research: the good, the bad and the ugly , 2001, Nature Reviews Neuroscience.
[36] Irving L. Weissman,et al. A Genetic Analysis of Neural Progenitor Differentiation , 2001, Neuron.
[37] D. Geschwind,et al. Mice, microarrays, and the genetic diversity of the brain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[38] E. Wang,et al. Rapid up-regulation of peptide elongation factor EF-1alpha protein levels is an immediate early event during oxidative stress-induced apoptosis. , 2000, Experimental cell research.
[39] Wen-Lang Lin,et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein , 2000, Nature Genetics.
[40] S. Korsmeyer,et al. BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.
[41] J. Ávila,et al. Polymerization of tau peptides into fibrillar structures. The effect of FTDP‐17 mutations , 1999, FEBS letters.
[42] C. Duijn,et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. , 1999, American journal of human genetics.
[43] Iris Salecker,et al. Polyglutamine-Expanded Human Huntingtin Transgenes Induce Degeneration of Drosophila Photoreceptor Neurons , 1998, Neuron.
[44] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[45] E. Wang,et al. Apoptosis rate can be accelerated or decelerated by overexpression or reduction of the level of elongation factor-1 alpha. , 1998, Experimental cell research.
[46] D. Constam,et al. Cloning of the Human Puromycin‐Sensitive Aminopeptidase and Evidence for Expression in Neurons , 1997, Journal of neurochemistry.
[47] J. Kuret,et al. The Structural Basis of Monoclonal Antibody Alz50's Selectivity for Alzheimer's Disease Pathology* , 1996, The Journal of Biological Chemistry.
[48] I. Grundke‐Iqbal,et al. Glycosylation of microtubule–associated protein tau: An abnormal posttranslational modification in Alzheimer's disease , 1996, Nature Medicine.
[49] Gerald M. Rubin,et al. Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death , 1995, Cell.
[50] M. Mercken,et al. Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF‐tau , 1995, FEBS letters.
[51] L. Hersh,et al. Degradation of Dynorphin‐Related Peptides by the Puromycin‐Sensitive Aminopeptidase and Aminopeptidase M , 1995, Journal of neurochemistry.
[52] G. Huber,et al. Purification and Characterization of a Novel Metalloprotease from Human Brain with the Ability to Cleave Substrates Derived from the N-Terminus of β-Amyloid Protein , 1994 .
[53] E. Mandelkow,et al. The switch of tau protein to an Alzheimer‐like state includes the phosphorylation of two serine‐proline motifs upstream of the microtubule binding region. , 1992, The EMBO journal.
[54] J. Trojanowski,et al. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. , 1991, Science.
[55] Khadija Iqbal,et al. Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease , 1991, Brain Research.
[56] P. Fisher,et al. Interconversion of Drosophila nuclear lamin isoforms during oogenesis, early embryogenesis, and upon entry of cultured cells into mitosis , 1989, The Journal of cell biology.
[57] R. Crowther,et al. Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. , 1989, The EMBO journal.
[58] L. Hersh,et al. Studies on the Tissue Distribution of the Puromycin‐Sensitive Enkephalin‐Degrading Aminopeptidases , 1988, Journal of neurochemistry.
[59] J. Trojanowski,et al. Epitopes that span the tau molecule are shared with paired helical filaments , 1988, Neuron.
[60] K. White,et al. The locus elav of Drosophila melanogaster is expressed in neurons at all developmental stages. , 1988, Developmental biology.
[61] H. Wiśniewski,et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[62] G. Rubin,et al. Transposition of cloned P elements into Drosophila germ line chromosomes. , 1982, Science.
[63] G. Rubin,et al. Genetic transformation of Drosophila with transposable element vectors. , 1982, Science.
[64] I. Grundke‐Iqbal,et al. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease , 2008, Molecular Neurobiology.
[65] M. Fortini,et al. gamma-cleavage-independent functions of presenilin, nicastrin, and Aph-1 regulate cell-junction organization and prevent tau toxicity in vivo. , 2007, Neuron.
[66] Y. Tu,et al. Distinct roles of two structurally closely related focal adhesion proteins, alpha-parvins and beta-parvins, in regulation of cell morphology and survival. , 2004, The Journal of biological chemistry.
[67] P. S. St George-Hyslop,et al. gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? , 2002, Nature reviews. Neuroscience.
[68] J. Trojanowski,et al. Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.
[69] D L Price,et al. Alzheimer's disease: genetic studies and transgenic models. , 1998, Annual review of genetics.
[70] M. Viitanen,et al. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type , 1993, Journal of neural transmission. Parkinson's disease and dementia section.
[71] Rae Baxter,et al. Acknowledgments.-The authors would like to , 1982 .